Anžej Doma Saša, Kraljić Nika, Kristan Aleša, Debeljak Nataša, Maver Aleš, Pajič Tadej, Preložnik Zupan Irena
Hematology Department, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Front Med (Lausanne). 2024 Sep 6;11:1440712. doi: 10.3389/fmed.2024.1440712. eCollection 2024.
Congenital erythrocytosis (CE) is increasingly recognized as the cause of erythrocytosis in patients in whom polycythemia vera and secondary acquired causes have been excluded. The aim of our study was to determine possible genetic background in patients with idiopathic erythrocytosis.
40 patients with idiopathic erythrocytosis, referred to our institution in a 5-year period, were analyzed. We collected data on erythropoietin (Epo) levels, hemoglobin (Hgb), hematocrit (Hct), erythrocyte count, age, gender, past thrombotic events, concomitant diseases, and smoking status. CE was tested using next-generation sequencing (NGS), in the majority of patients also measurement of P50 and Hgb electrophoresis were performed. Patients with signs of iron overload were tested for genetic variants in the gene.
The median patient age at analysis was 46.5 years (range 22-73), with 37 out of 40 being males (93 %). The median Hgb, Hct and red blood cells count were 180 g/L, 0.51, 5.985 x 10/L in men and 171 g/L, 0.50 and 5.68 x 10/L in women, respectively. Epo levels were decreased in three, increased in one patient and within the normal range in the rest (median 7.55 mIU/mL; range 2.90-19.50). Eight patients (20 %) smoked. 32 (80 %) were treated with low-dose aspirin, and 20 (50 %) underwent at least one phlebotomy. Thromboembolic events were recorded in 2 patients (5 %). P50 was measured in 20 out of 40 patients, and it was above 24 mm Hg (3.12 kPa) in all of them. Hemoglobin electrophoresis was performed in 73 % of patients, with no abnormal Hgb detected. Variants in the gene were found in 8 out of 40 patients (20 %), but in only one patient the results were associated with an increased risk for hemochromatosis. Although no pathogenic variants for CE were detected by NGS, two variants of uncertain significance, namely (NM_022051.2):c.1072C>T (p.(Pro358Ser)) and (NM_022051.2):c.1124A>G (p.(Glu375Gly)) were identified as strong etiologic candidates.
CE is an extremely rare condition. Genetic testing is advised in young individuals with a long-standing persistent erythrocytosis, possibly with a family history and after exclusion of more frequent secondary causes and polycytemia vera.
先天性红细胞增多症(CE)越来越被认为是真性红细胞增多症和继发性后天性病因被排除的患者红细胞增多的原因。我们研究的目的是确定特发性红细胞增多症患者可能的遗传背景。
分析了在5年期间转诊至我们机构的40例特发性红细胞增多症患者。我们收集了有关促红细胞生成素(Epo)水平、血红蛋白(Hgb)、血细胞比容(Hct)、红细胞计数、年龄、性别、既往血栓形成事件、伴随疾病和吸烟状况的数据。使用下一代测序(NGS)检测CE,大多数患者还进行了P50测量和血红蛋白电泳。对有铁过载迹象的患者进行该基因的基因变异检测。
分析时患者的中位年龄为46.5岁(范围22 - 73岁),40例中有37例为男性(93%)。男性的Hgb、Hct和红细胞计数中位数分别为180 g/L、0.51、5.985×10/L,女性分别为171 g/L、0.50和5.68×10/L。3例患者Epo水平降低,1例患者升高,其余患者Epo水平在正常范围内(中位数7.55 mIU/mL;范围2.90 - 19.50)。8例患者(20%)吸烟。32例(80%)接受低剂量阿司匹林治疗,20例(50%)至少进行过一次放血治疗。2例患者(5%)记录有血栓栓塞事件。40例患者中有20例测量了P50,所有患者的P50均高于24 mmHg(3.12 kPa)。73%的患者进行了血红蛋白电泳,未检测到异常血红蛋白。40例患者中有8例(20%)发现该基因变异,但只有1例患者的结果与血色素沉着症风险增加相关。尽管通过NGS未检测到CE的致病变异,但确定了两个意义不确定的变异,即(NM_022051.2):c.1072C>T(p.(Pro358Ser))和(NM_022051.2):c.1124A>G(p.(Glu375Gly))作为强烈的病因候选者。
CE是一种极其罕见的疾病。建议对长期持续性红细胞增多症的年轻个体进行基因检测,可能有家族史且排除了更常见的继发性病因和真性红细胞增多症后。